Skip to main content
Equibles

MORGAN STANLEY

Position in AVXL — Anavex Life Sciences Corp.

CIK 895421 NEW YORK, NY
Back to AVXL Full portfolio

Position in AVXL

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$504,950
-$593,330 QoQ
Shares Held
194,963
-45.5% QoQ
Ownership
0.210%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 179 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 72% Shared 0% None 28%

Common Shares in AVXL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. AVXL ranks #277 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in AVXL

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $504,950 194,963
2026-03-31 $1,098,280 357,747
2025-12-31 $1,690,484 474,856
2025-09-30 $4,985,315 560,148
2025-06-30 $5,782,846 627,207
2025-03-31 $7,419,363 864,728
2024-12-31 $9,710,664 904,159
2024-09-30 $4,081,388 718,555
2024-06-30 $1,847,681 437,840
2024-03-31 $1,733,802 340,630
2023-12-31 $4,210,007 452,203
2023-09-30 $1,783,189 272,243
2023-06-30 $2,214,721 272,414
2023-03-31 $2,240,932 261,486
2022-12-31 $3,551,049 383,483
2022-09-30 $2,251,520 218,171
2022-06-30 $8,456,594 844,815
2022-03-31 $9,178,419 745,607
2021-12-31 $6,194,106 357,215
2021-09-30 $4,476,495 249,387
2021-06-30 $6,210,443 271,673
2021-03-31 $1,275,892 85,344
2020-12-31 $450,456 83,418
2020-09-30 $109,531 24,073
2020-06-30 $205,218 41,711
2020-03-31 $90,757 28,812